Article metrics

Original research
Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial

 

Online download statistics by month:

Online download statistics by month: April 2022 to May 2022

AbstractFullPdf
Apr 2022925943484
May 2022708717362
Total16331660846